| pubmed-article:14640541 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0080194 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0050587 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C2916808 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0456387 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0678594 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0443288 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C1705938 | lld:lifeskim |
| pubmed-article:14640541 | lifeskim:mentions | umls-concept:C1527178 | lld:lifeskim |
| pubmed-article:14640541 | pubmed:issue | 25 | lld:pubmed |
| pubmed-article:14640541 | pubmed:dateCreated | 2003-12-3 | lld:pubmed |
| pubmed-article:14640541 | pubmed:abstractText | A series of conformationally restricted analogues of milnacipran, a weak NMDA receptor antagonist, were designed by a method based on allylic strain. The conformational analysis study showed that the allylic-strain-based conformational restriction indeed occurred and that the affinity for the NMDA receptor was efficiently improved by the conformational restriction. | lld:pubmed |
| pubmed-article:14640541 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14640541 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14640541 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14640541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14640541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14640541 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14640541 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14640541 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:14640541 | pubmed:issn | 0022-2623 | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:MatsudaAkiraA | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:ShutoSatoshiS | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:TsujitaRyuich... | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:YamamotoTamot... | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:OhmoriYutakaY | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:YamashitaAkit... | lld:pubmed |
| pubmed-article:14640541 | pubmed:author | pubmed-author:TaniuchiKakuK | lld:pubmed |
| pubmed-article:14640541 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14640541 | pubmed:day | 4 | lld:pubmed |
| pubmed-article:14640541 | pubmed:volume | 46 | lld:pubmed |
| pubmed-article:14640541 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14640541 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14640541 | pubmed:pagination | 5326-33 | lld:pubmed |
| pubmed-article:14640541 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:meshHeading | pubmed-meshheading:14640541... | lld:pubmed |
| pubmed-article:14640541 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14640541 | pubmed:articleTitle | A method for designing conformationally restricted analogues based on allylic strain: synthesis of a novel class of noncompetitive NMDA receptor antagonists having the acrylamide structure. | lld:pubmed |
| pubmed-article:14640541 | pubmed:affiliation | Institute for Life Science Research, Asahi Kasei Co, Ltd, Ohito-cho, Shizuoka 410-2321, Japan. | lld:pubmed |
| pubmed-article:14640541 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14640541 | pubmed:publicationType | In Vitro | lld:pubmed |
| pubmed-article:14640541 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:14640541 | lld:chembl |
